UBS AM’s Castle Biosciences CSTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.1M | Buy |
102,742
+34,711
| +51% | +$709K | ﹤0.01% | 2116 |
|
|
2025
Q1 | $1.36M | Buy |
68,031
+2,013
| +3% | +$40.3K | ﹤0.01% | 2179 |
|
|
2024
Q4 | $1.76M | Buy |
66,018
+10,486
| +19% | +$279K | ﹤0.01% | 2114 |
|
|
2024
Q3 | $1.58M | Sell |
55,532
-604
| -1% | -$17.2K | ﹤0.01% | 2164 |
|
|
2024
Q2 | $1.22M | Buy |
56,136
+24,348
| +77% | +$530K | ﹤0.01% | 2269 |
|
|
2024
Q1 | $704K | Buy |
31,788
+4,527
| +17% | +$100K | ﹤0.01% | 2176 |
|
|
2023
Q4 | $588K | Hold |
27,261
| – | – | ﹤0.01% | 2266 |
|
|
2023
Q3 | $460K | Sell |
27,261
-130,061
| -83% | -$2.2M | ﹤0.01% | 2328 |
|
|
2023
Q2 | $3.57M | Hold |
157,322
| – | – | ﹤0.01% | 1381 |
|
|
2023
Q1 | $3.57M | Sell |
157,322
-1,741
| -1% | -$39.6K | ﹤0.01% | 1381 |
|
|
2022
Q4 | $3.74M | Buy |
159,063
+12,717
| +9% | +$299K | ﹤0.01% | 1264 |
|
|
2022
Q3 | $3.82M | Sell |
146,346
-10,806
| -7% | -$282K | ﹤0.01% | 1294 |
|
|
2022
Q2 | $3.45M | Sell |
157,152
-20,679
| -12% | -$454K | ﹤0.01% | 1358 |
|
|
2022
Q1 | $7.98M | Sell |
177,831
-9,412
| -5% | -$422K | ﹤0.01% | 1161 |
|
|
2021
Q4 | $8.03M | Buy |
187,243
+8,588
| +5% | +$368K | ﹤0.01% | 1208 |
|
|
2021
Q3 | $11.9M | Sell |
178,655
-8,152
| -4% | -$542K | ﹤0.01% | 1023 |
|
|
2021
Q2 | $13.7M | Sell |
186,807
-6,771
| -3% | -$497K | 0.01% | 997 |
|
|
2021
Q1 | $13.3M | Buy |
193,578
+3,410
| +2% | +$233K | 0.01% | 988 |
|
|
2020
Q4 | $12.8M | Sell |
190,168
-68,969
| -27% | -$4.63M | 0.01% | 969 |
|
|
2020
Q3 | $13.3M | Buy |
259,137
+95,058
| +58% | +$4.89M | 0.01% | 869 |
|
|
2020
Q2 | $6.18M | Buy |
164,079
+8,498
| +5% | +$320K | ﹤0.01% | 1044 |
|
|
2020
Q1 | $4.64M | Buy |
+155,581
| New | +$4.64M | ﹤0.01% | 1072 |
|